IMMP vs IMMX

Immutep Limited vs Immix Biopharma, Inc. — Valuation Comparison 2026

IMMP

Biotechnology
Immutep Limited
Quality
4.9
out of 10
Value Trap
24
SAFE
Price
$0.44
Last close
Models
9/13
Active
VS

IMMX

Biotechnology
Immix Biopharma, Inc.
Quality
5.1
out of 10
Value Trap
30
LOW
Price
$8.84
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType IMMP Fair ValueIMMP Upside IMMX Fair ValueIMMX Upside
Bayesian DCF Intrinsic $0.30 -33.5% $2.98 -66.3%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.68 +52.4% $1.23 -86.1%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for IMMP vs IMMX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IMMP vs IMMX — Which Stock Is More Undervalued?

IMMX scores higher with a 5.1/10 quality rating vs IMMP's 4.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Immutep Limited (IMMP) and Immix Biopharma, Inc. (IMMX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IMMP currently trades at $0.44 with a QOC of 4.9/10, while IMMX trades at $8.84 with a QOC of 5.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).